These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 759296)
1. HEW promotes wider use of generic drugs, predicts savings under reimbursement plan. Hospitals; 1979 Feb; 53(3):17. PubMed ID: 759296 [No Abstract] [Full Text] [Related]
2. Generic drug substitutes can save $20 million. Simler SL Mod Healthc; 1979 Feb; 9(2):16. PubMed ID: 153449 [No Abstract] [Full Text] [Related]
3. Industry warily eyes new Medicare drug plan. Vastag B Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141 [No Abstract] [Full Text] [Related]
4. The association of insurance type with costs of dispensed drugs. Mott DA; Kreling DH Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015 [TBL] [Abstract][Full Text] [Related]
5. The MAC program and advisors to the government. Shubin S Hosp Formul; 1981 Aug; 16(8):869-72, 877-9. PubMed ID: 10252371 [No Abstract] [Full Text] [Related]
8. Cost sharing, caps on benefits, and the chronically ill--a policy mismatch. Thorpe KE N Engl J Med; 2006 Jun; 354(22):2385-6. PubMed ID: 16738277 [No Abstract] [Full Text] [Related]
9. New federal guidelines: a green light from government. Gosselin RA Hosp Formul; 1978 Jul; 13(7):546-9. PubMed ID: 10308293 [No Abstract] [Full Text] [Related]
10. 25th annual prescription survey: Albany College of Pharmacy of Union University. DeNuzzo RV Med Mark Media; 1981 Apr; 16(4):31-2, 34-51. PubMed ID: 10250762 [No Abstract] [Full Text] [Related]
11. Two U.S. agencies offer generic drug law. Fisher MJ Natl Underwrit Life Health; 1979 Jan; 83(2):2, 7. PubMed ID: 10239881 [No Abstract] [Full Text] [Related]
13. The piggyback dilemma. Tanner DJ Hosp Pharm; 1978 Jun; 13(6):326. PubMed ID: 10307644 [No Abstract] [Full Text] [Related]
14. The nature and consequences of policies intended to contain costs in outpatient drug insurance programs. Reutzel TJ Clin Ther; 1993; 15(4):752-64. PubMed ID: 8221825 [TBL] [Abstract][Full Text] [Related]
16. Medicare overpaid dollar 110 million for part B drugs. Med Health; 2006 Mar; 60(13):2-3. PubMed ID: 16562555 [No Abstract] [Full Text] [Related]
17. Maximum allowable cost for drugs. Hosp Formul; 1975 Mar; 10(3):116, 119-20. PubMed ID: 10237830 [No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558 [No Abstract] [Full Text] [Related]
19. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy. Paul SH Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270 [No Abstract] [Full Text] [Related]
20. 'Generic substitution' in New Jersey, 1979-87. Culkin TT; Mendell S Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]